- Published at
- by markets.businessinsider.com
positive
positive
Seelos Agrees To Repurchase Significant Portion Of Royalties Due On SLS-002
(RTTNews) - Seelos Therapeutics, Inc. (SEEL) reported an amendment of the agreement with Vyera Pharmaceuticals AG for the development of SLS-002 t...